LITHIUM CARBONATE Drug Patent Profile
✉ Email this page to a colleague
When do Lithium Carbonate patents expire, and when can generic versions of Lithium Carbonate launch?
Lithium Carbonate is a drug marketed by Able, Alembic Ltd, Apotex Inc, Glenmark Pharms Ltd, Hetero Labs Ltd Iii, Hikma, Norvium Bioscience, Usl Pharma, Watson Labs, Alembic, Glenmark Pharms Inc, Heritage Pharma, Hikma Intl Pharms, Mylan Pharms Inc, Unique, Pfizer, and Sun Pharm Inds Inc. and is included in twenty-nine NDAs.
The generic ingredient in LITHIUM CARBONATE is lithium carbonate. There are fifteen drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the lithium carbonate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Lithium Carbonate
A generic version of LITHIUM CARBONATE was approved as lithium carbonate by HIKMA on January 29th, 1982.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for LITHIUM CARBONATE?
- What are the global sales for LITHIUM CARBONATE?
- What is Average Wholesale Price for LITHIUM CARBONATE?
Summary for LITHIUM CARBONATE
| US Patents: | 0 |
| Applicants: | 17 |
| NDAs: | 29 |
| Finished Product Suppliers / Packagers: | 23 |
| Raw Ingredient (Bulk) Api Vendors: | 133 |
| Clinical Trials: | 99 |
| Patent Applications: | 2,019 |
| Drug Prices: | Drug price information for LITHIUM CARBONATE |
| What excipients (inactive ingredients) are in LITHIUM CARBONATE? | LITHIUM CARBONATE excipients list |
| DailyMed Link: | LITHIUM CARBONATE at DailyMed |
See drug prices for LITHIUM CARBONATE
Recent Clinical Trials for LITHIUM CARBONATE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Mental Health Services in the Capital Region, Denmark | Phase 4 |
| Second Xiangya Hospital of Central South University | Phase 1/Phase 2 |
| First Affiliated Hospital of Chongqing Medical University | Phase 1/Phase 2 |
Pharmacology for LITHIUM CARBONATE
| Drug Class | Mood Stabilizer |
Medical Subject Heading (MeSH) Categories for LITHIUM CARBONATE
Anatomical Therapeutic Chemical (ATC) Classes for LITHIUM CARBONATE
US Patents and Regulatory Information for LITHIUM CARBONATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hikma Intl Pharms | LITHIUM CARBONATE | lithium carbonate | TABLET, EXTENDED RELEASE;ORAL | 076490-001 | Jun 17, 2003 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Heritage Pharma | LITHIUM CARBONATE | lithium carbonate | TABLET, EXTENDED RELEASE;ORAL | 205532-001 | Sep 29, 2016 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Mylan Pharms Inc | LITHIUM CARBONATE | lithium carbonate | TABLET, EXTENDED RELEASE;ORAL | 202288-001 | Jun 29, 2012 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Heritage Pharma | LITHIUM CARBONATE | lithium carbonate | TABLET, EXTENDED RELEASE;ORAL | 076366-001 | Aug 21, 2003 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
